The Trusted Standard in Health Intelligence
EksoNR Neurorehabilitation
Robotics
4.6

EksoNR Neurorehabilitation

Robotic exoskeleton helping stroke and spinal cord patients walk again

Founded

2005

HQ

San Rafael, USA

Price

Clinical System

Website

eksobionics.com

Exoskeleton Rehabilitation Neuro FDA-cleared

Overview

EksoNR is an FDA-cleared robotic exoskeleton for neurorehabilitation. It helps patients with stroke, spinal cord injury, and brain injury regain the ability to walk through adaptive, sensor-driven gait training in clinical settings.

Why It's Notable

Clinically proven to improve walking outcomes. Used in 300+ rehabilitation centers globally.

How It Works

The exoskeleton straps onto the patient's lower body. Sensors detect the patient's intended movements and provide motorized assistance proportional to their ability. As the patient improves, the robot reduces assistance, promoting neuroplasticity.

Key Features

Adaptive assist — adjusts to patient ability
Real-time gait analytics
Variable Assist software
Used for stroke, SCI, and TBI
Clinical outcome tracking dashboard
FDA 510(k) cleared

Team & Background

Originally developed at UC Berkeley. Now a Parker Hannifin company.

Disclaimer: This information is for educational purposes only. Health.AI does not endorse, sell, or receive compensation from any listed product. Always consult your healthcare provider before using any health technology. Product claims are based on manufacturer data and published research at the time of listing.